Insightful Analysis of Invesco EQV European Equity Fund (Trades, Portfolio)'s Q1 2024 Investment Decisions Warning! GuruFocus has detected 5 Warning Sign with OCSE:NOVO B. Invesco EQV European Equity Fund (Trades, Portfolio), known for its strategic investments in high-growth European markets, has revealed its N-PORT filing for the first quarter of 2024. The Fund, which commenced on November 3, 1997, is managed by Invesco Ltd. and focuses on a diversified portfolio of quality companies at reasonable prices. The investment team prioritizes strong fundamentals and the potential for sustainable earnings growth when selecting stocks for the portfolio. Invesco EQV European Equity Fund's Strategic Moves: Spotlight on CRH PLC with a 2.17% Portfolio Stake Summary of New Buys Invesco EQV European Equity Fund (Trades, Portfolio) expanded its portfolio with 5 new stocks. Noteworthy additions include: CRH PLC (NYSE:CRH), with 143,280 shares, making up 2.17% of the portfolio and valued at $10,281,770 million. STMicroelectronics NV (MIL:STMMI), comprising 146,192 shares, which is about 1.36% of the portfolio, with a total value of 6,418,930. Rentokil Initial PLC (LSE:RTO), with 764,966 shares, accounting for 0.83% of the portfolio and a total value of 3,939,380. Key Position Increases The Fund also bolstered its positions in 9 stocks, with significant increases in: Compagnie Financiere Richemont SA (XSWX:CFR), adding 17,898 shares for a total of 57,986 shares. This represents a 44.65% increase in share count, impacting the portfolio by 0.56%, and valued at CHF8,612,920. Capgemini SE (XPAR:CAP), with an additional 11,009 shares, bringing the total to 44,729 shares. This adjustment marks a 32.65% increase in share count, with a total value of 9,944,210. Summary of Sold Out Positions The Fund exited 3 holdings in the first quarter of 2024, including: CRH PLC (LSE:CRH): All 153,899 shares were sold, impacting the portfolio by -1.94%. Carlsberg A/S (OCSE:CARL B): The complete liquidation of 44,192 shares resulted in a -1.23% portfolio impact. Key Position Reductions Reductions were made in 39 stocks, with notable changes in: Danieli & C. Officine Meccaniche SpA (MIL:DANR), reduced by 158,471 shares, leading to a -40.54% decrease in shares and a -0.75% portfolio impact. The stock's average trading price was 20.9 during the quarter, with returns of 11.90% over the past 3 months and 12.67% year-to-date. DCC PLC (LSE:DCC), reduced by 57,078 shares, resulting in a -26.71% share count reduction and a -0.74% portfolio impact. The stock traded at an average price of 54.57 during the quarter, with returns of 0.10% over the past 3 months and -0.31% year-to-date. Portfolio Overview As of the first quarter of 2024, Invesco EQV European Equity Fund (Trades, Portfolio)'s portfolio comprised 53 stocks. The top holdings included 4.09% in Novo Nordisk A/S (OCSE:NOVO B), 3.6% in Investor AB (OSTO:INVE B), 3.58% in Nestle SA (XSWX:NESN), 3.13% in RELX PLC (LSE:REL), and 3.05% in Chemical Works of Gedeon Richter PLC (BUD:RICHTER). The investments span across 10 of the 11 industries, with significant exposure in Industrials, Healthcare, Financial Services, Consumer Defensive, Consumer Cyclical, Energy, Technology, Communication Services, Basic Materials, and Real Estate. Invesco EQV European Equity Fund's Strategic Moves: Spotlight on CRH PLC with a 2.17% Portfolio Stake Invesco EQV European Equity Fund's Strategic Moves: Spotlight on CRH PLC with a 2.17% Portfolio Stake This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Invesco EQV European Equity Fund's Strategic Moves: Spotlight on CRH PLC with a 2. ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...